Our hypothesis is partly confirmed experimentally, as supplementation with WGLL, a low-cost and reasonable natural product, suppresses the symptoms of MCT-induced pulmonary hypertension in a rat model, but its protective effects on cardiovascular system seem to be independent from the PDE5 pathway; thus underlying mechanisms need further investigations. This evidence concerns the gene PDE5A and pulmonary arterial hypertension.